Search Within

Department of Medicine

Formats
  1. Journal Article (19591)
  2. Meeting Abstract (16038)
  3. Review (1150)
  4. Book Section (934)
  5. Editorial (609)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22321)
  2. Hematologic Malignancies, Division of (13276)
  3. Center for Hematologic Malignancies (11060)
  4. GSK Faculty (10645)
  5. Survivorship Research (9329)
  6. Division of Subspecialty Medicine (7534)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1068)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2111)

More Publishers

Results (39619)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Single-cell atlas of diffuse large B-cell lymphoma reveals integrated malignant B cell and tumor microenvironment characteristics associated with clinical response
    Meeting Abstract

    Baaklini, S.; Sarrabay, A.; Mazuel, A.; Escaliere, B.; Dong, C.; Barthelemy, C.; Gil, L.; Dahbi, L.; Mossadegh-Keller, N.; Van Acker, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Fixed-duration epcoritamab in combination with bendamustine + rituximab for first-line treatment of follicular lymphoma: Initial results from EPCORE NHL-2 Arm 3
    Meeting Abstract

    Brody, J.; Falchi, L.; Vitolo, U.; Nijland, M.; Offner, F.; Snauwaert, S.; Patah, P.; Marek, J.; Morehouse, C.; Steele, A. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Assessing role of comorbidities in treatment selection for older patients with acute myeloid leukemia
    Meeting Abstract

    Grenet, J.; Easwar, N.; Jain, A. G.; Burkart, M.; Ma, X.; Christos, P.; Ritchie, E. K.; Samuel, M.; Kaner, J. D.; Canaani, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Development of the ASH Research Collaborative Multiple Myeloma Program: A multicenter, real-world evidence generation network
    Meeting Abstract

    Kumar, S.; Wood, W. A.; Anderson, K. C.; Semmel, E. A.; James, S.; Neuberg, D. S.; Hewitt, K.; Schroeder, M. A.; Chung, D. J.; Rosenberg, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Transcriptomic and epigenomic landscape of hairy cell leukemia at single-cell resolution
    Meeting Abstract

    Eton, E. O.; Ganesan, S.; Murray, R. M.; Durham, B. H.; Park, J. H.; Abdel-Wahab, O.; Landau, D. A.
    Blood (2024)

    Fulltext@MSK | Save
  • A phase 1, open-label, dose escalation and dose expansion, multicenter clinical trial to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of lomonitinib (ZE46-0134) in adults with FLT3-mutated relapsed or refractory acute myeloid leukemia
    Meeting Abstract

    Lin, T. L.; Koenig, K. L.; Swords, R. T.; Stein, E. M.; Baer, M. R.; Stock, W.; Madanat, Y. F.; Olin, R.; Blum, W.; Schiller, G. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Hematologic improvement experienced by pacritinib-treated patients with myelofibrosis in real-world clinical settings
    Meeting Abstract

    Marrone, M.; Morere, L.; Oladapo, A.; Suthar, P.; Sura, T.; Vasudevan, A.; Vredenburg, M.; Zeng, J.; Rampal, R.; Mascarenhas, J. O.
    Blood (2024)

    Fulltext@MSK | Save
  • 24-hour urine testing does not add value to multiple myeloma response assessments: A secondary analysis of BMT CTN 0702
    Meeting Abstract

    Banerjee, R.; Fritz, A. R.; Akhtar, O. S.; Freeman, C. L.; Cowan, A. J.; Shah, N.; Landau, H. J.; Kumar, S.; Vogl, D. T.; Efebera, Y. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Interim results from a phase 2 pivotal study (DALY II USA) of tandem CD20-CD19-directed non-cryopreserved CAR-T cells - Zamtocabtagene autoleucel (Zamto-Cel) in patients with relapsed/refractory diffuse large B cell lymphoma
    Meeting Abstract

    Shah, N. N.; Maziarz, R. T.; Jacobson, C. A.; Johnston, P. B.; Abhyankar, S.; Isufi, I.; Perales, M. A.; Ghosh, M.; Ulrickson, M.; Rosenthal, A. C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • The first encounter with oncology: Patient experience and requisite trust
    Book Section

    Ahluwalia, A.; Epstein, A.
    In McFarland, D. C.; Grassi, L.; Silver, S. M.; Riba, M. B. (Eds.) The Complex Role of Patient Trust in Oncology (2024)

    Fulltext@MSK | Save